Infertility Management in Lean Versus Obese PCOS

Patil, Madhuri

doi:10.1007/978-3-030-63650-0_9

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 59 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The evidence supports its prognostic role in addition to the endocrine or metabolic markers commonly seen in PCOS. [ 92 ] Translating this insight into clinical practice offers an opportunity for effective pre-treatment counselling and planning. It may help avoid protracted courses of medications and timely recourse to effective treatment strategies with added emotional and financial benefits.…”

Section: Discussionmentioning

confidence: 99%

Anti-Mullerian Hormone and Fertility Treatment Decisions in Polycystic Ovary Syndrome: A Literature Review

Shah,

Jirge

2024

Journal of Human Reproductive Sciences

View full text Add to dashboard Cite

Anti-Mullerian hormone is a robust marker of ovarian reserve and ovarian response in in vitro fertilisation (IVF). However, its role extends beyond improving the safety of IVF by aiding in choosing appropriate protocols and dosing. This review looks at the value of pre-treatment anti-Mullerian hormone (AMH) value in choosing the appropriate modality of treatment and its predictive ability for the outcomes of such treatment. It briefly addresses the factors that may modulate AMH levels and make clinical decision-making challenging.

show abstract

Section: Discussionmentioning

confidence: 99%